Peer-influenced content. Sources you trust. No registration required. This is HCN.
Conexiant
A post hoc SURPASS-CVOT analysis associated tirzepatide with fewer six-component cardiorenal events than dulaglutide in patients with type 2 diabetes and established ASCVD.
Cardiology May 5th 2026
Parkinson’s News Today
Switching Parkinson’s patients to Crexont added more than three hours of daily symptom control in interim Phase 4 data. Here’s how to read an open-label, sponsor-run signal.
Neurology April 30th 2026
The American Academy of Sleep Medicine just clarified where combination therapy fits for chronic insomnia. Spoiler: CBT-I still wins, but pharmacotherapy alone has a narrower role.
Epilepsy Currents
The American Epilepsy Society released the first dedicated treatment guideline for infantile epilepsy. Two strong surgical recommendations sit alongside conditional pharmacological and dietary guidance.
Medical News Today (MNT)
According to the Gould Registry, in 5,006 patients with ASCVD, only one in three patients had LDL cholesterol even less than 70mg/dl.
Cardiology April 10th 2026
Medical Professionals Reference (MPR)
Foundayo will be available via LillyDirect beginning April 6, with widespread availability through retail pharmacies and telehealth providers occurring soon after.
Endocrinology, Diabetes, Metabolism April 8th 2026
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS